Your browser doesn't support javascript.
Integrated Sustainable childhood Pneumonia and Infectious disease Reduction in Nigeria (INSPIRING) through whole system strengthening in Jigawa, Nigeria: study protocol for a cluster randomised controlled trial.
King, Carina; Burgess, Rochelle Ann; Bakare, Ayobami A; Shittu, Funmilayo; Salako, Julius; Bakare, Damola; Uchendu, Obioma C; Iuliano, Agnese; Isah, Adamu; Adams, Osebi; Haruna, Ibrahim; Magama, Abdullahi; Ahmed, Tahlil; Ahmar, Samy; Cassar, Christine; Valentine, Paula; Olowookere, Temitayo Folorunso; MacCalla, Matthew; Graham, Hamish R; McCollum, Eric D; Falade, Adegoke G; Colbourn, Tim.
  • King C; Department of Global Public Health, Karolinska Institutet, Tomtebodavägen 18, 171 65, Stockholm, Sweden. carina.king@ki.se.
  • Burgess RA; Institute for Global Health, University College London, London, UK. carina.king@ki.se.
  • Bakare AA; Institute for Global Health, University College London, London, UK.
  • Shittu F; Department of Global Public Health, Karolinska Institutet, Tomtebodavägen 18, 171 65, Stockholm, Sweden.
  • Salako J; Department of Community Medicine, University College Hospital, Ibadan, Nigeria.
  • Bakare D; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
  • Uchendu OC; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
  • Iuliano A; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
  • Isah A; Department of Community Medicine, University College Hospital, Ibadan, Nigeria.
  • Adams O; Department of Community Medicine, University of Ibadan, Ibadan, Nigeria.
  • Haruna I; Institute for Global Health, University College London, London, UK.
  • Magama A; Save the Children International, Abuja, Nigeria.
  • Ahmed T; Save the Children International, Abuja, Nigeria.
  • Ahmar S; Save the Children International, Abuja, Nigeria.
  • Cassar C; Save the Children International, Abuja, Nigeria.
  • Valentine P; Save the Children UK, London, UK.
  • Olowookere TF; Save the Children UK, London, UK.
  • MacCalla M; Save the Children UK, London, UK.
  • Graham HR; Save the Children UK, London, UK.
  • McCollum ED; GlaxoSmithKline (GSK), Lagos, Nigeria.
  • Falade AG; GlaxoSmithKline (GSK), Brentford, UK.
  • Colbourn T; Department of Paediatrics, University College Hospital, Ibadan, Nigeria.
Trials ; 23(1): 95, 2022 Jan 31.
Article in English | MEDLINE | ID: covidwho-1662421
ABSTRACT

BACKGROUND:

Child mortality remains unacceptably high, with Northern Nigeria reporting some of the highest rates globally (e.g. 192/1000 live births in Jigawa State). Coverage of key protect and prevent interventions, such as vaccination and clean cooking fuel use, is low. Additionally, knowledge, care-seeking and health system factors are poor. Therefore, a whole systems approach is needed for sustainable reductions in child mortality.

METHODS:

This is a cluster randomised controlled trial, with integrated process and economic evaluations, conducted from January 2021 to September 2022. The trial will be conducted in Kiyawa Local Government Area, Jigawa State, Nigeria, with an estimated population of 230,000. Clusters are defined as primary government health facility catchment areas (n = 33). The 33 clusters will be randomly allocated (11) in a public ceremony, and 32 clusters included in the impact evaluation. The trial will evaluate a locally adapted 'whole systems strengthening' package of three evidence-based

methods:

community men's and women's groups, Partnership Defined Quality Scorecard and healthcare worker training, mentorship and provision of basic essential equipment and commodities. The primary outcome is mortality of children aged 7 days to 59 months. Mortality will be recorded prospectively using a cohort design, and secondary outcomes measured through baseline and endline cross-sectional surveys. Assuming the following, we will have a minimum detectable effect size of 30% (a) baseline mortality of 100 per 1000 livebirths, (b) 4480 compounds with 3 eligible children per compound, (c) 80% power, (d) 5% significance, (e) intra-cluster correlation of 0.007 and (f) coefficient of variance of cluster size of 0.74. Analysis will be by intention-to-treat, comparing intervention and control clusters, adjusting for compound and trial clustering.

DISCUSSION:

This study will provide robust evidence of the effectiveness and cost-effectiveness of community-based participatory learning and action, with integrated health system strengthening and accountability mechanisms, to reduce child mortality. The ethnographic process evaluation will allow for a rich understanding of how the intervention works in this context. However, we encountered a key challenge in calculating the sample size, given the lack of timely and reliable mortality data and the uncertain impacts of the COVID-19 pandemic. TRIAL REGISTRATION ISRCTN 39213655 . Registered on 11 December 2019.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Child / Female / Humans / Male Country/Region as subject: Africa Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2022 Document Type: Article Affiliation country: S13063-021-05859-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Child / Female / Humans / Male Country/Region as subject: Africa Language: English Journal: Trials Journal subject: Medicine / Therapeutics Year: 2022 Document Type: Article Affiliation country: S13063-021-05859-5